Liquid biopsy in breast cancer using NGS
NGS-based liquid biopsy assays combine an ultralow detection limit with broad genomic coverage and therefore offer a comprehensive testing strategy. However, the complexity of the wetlab process and the data processing have previously been challenging obstacles. In our webinar we will point out a possible approach on how to establish liquid biopsy in breast cancer using NGS.
Clinical application of liquid biopsy in breast cancer, The new xgen Prism DNA Library Prep Kit, Validation of liquid biopsy: knowing your analytical performance
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Simon von Ameln, Peter Verhasselt, Ben Liesfeld